Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, ...

Maintaining MSC identity during expansion—another factor affected by media choice—enhances consistency among production lots and, therefore, is important in the regulatory pathway. As they point out, ...

Provisions on research security, grant policies, indirect cost rates, and more are packed into the latest version of the NDAA ...

People come to Orlando to escape. With Disney World, SeaWorld and Universal Studios all in the area, there are endless ...

The rise of AMR in pathogenic bacteria poses serious challenges to the control and management of infectious diseases.

Friedreich’s ataxia is a genetic disorder that causes progressive damage to the nervous system and brain, leading to a loss ...

Dr Amna bint Abdullah Al Dahak, Minister of Climate Change and Environment (MOCCAE), inaugurated the first edition of the Biosecurity Forum, organised by the Ministry with broad participation from ...

Class of 2026 members Maya Butani and Daniel Yu have been named Marshall Scholars to pursue two years of graduate study in ...

Later-stage financing deals for cell and gene therapy companies reflects a broader derisking trend in the pharma industry.

Track leadership turnover at the Texas Medical Center with our list including presidents from UTHealth, Baylor College of ...

Iran and Uzbekistan will support the implementation of 10 research projects following a joint call by the Iran National ...

Cancer's 'Dark Matter' Outshines Neoantigens In Landmark Debate. EINPresswire/ -- UbiVac, a private, clinical-stage immuno-oncology company, debuted new data and Dark Matter emerged victorious in a hi ...